Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 20;19(12):7517.
doi: 10.3390/ijerph19127517.

Pharmacoeconomics Aspects of Antiepileptic Drugs in Pediatric Patients with Epilepsy

Dorota Kopciuch  1 , Jędrzej Fliciński  2 , Barbara Steinborn  2 , Anna Winczewska-Wiktor  2 , Anna Paczkowska  1 , Tomasz Zaprutko  1 , Piotr Ratajczak  1 , Elżbieta Nowakowska  3 , Krzysztof Kus  1
Affiliations

Pharmacoeconomics Aspects of Antiepileptic Drugs in Pediatric Patients with Epilepsy

Dorota Kopciuch et al. Int J Environ Res Public Health. .

Abstract

Objective: This study assessed the differentiation of treatment costs with newer and older antiepileptic drugs (AEDs) through its correlation with treatment effectiveness and an adverse event (AE) in pediatric patients with epilepsy (PPE).

Methods: PPE on monotherapy of AEDs for the last 6 months were screened for this study. Seizure frequency during the study was compared with that within 6 months before the study. The following parameters were also assessed: quality of life in epilepsy, Pittsburgh Sleep Quality Index, and Liverpool AEs Profile. An incremental cost-effectiveness ratio (ICER) analysis based on the costs of pharmacotherapy was also performed.

Results: Out of 80 PPE, 67 completed the study, and 13 PPE were lost after failing to meet the inclusion criteria. A total of 56.71% of PPE were on newer AEDs, and 43.28% were on older AEDs. Newer and older AEDs did not differ significantly in seizure frequency reduction and quality of life parameters, although these were improved significantly during the study period. As per ICER, newer AEDs need an additional EUR 36.82 per unit reduction in seizure frequency.

Conclusion: Newer AEDs have comparatively better efficacy, although not significantly better than older AEDs. However, the additional cost per unit improvement is quite high with newer AEDs, necessitating pharmacoeconomic consideration in pediatric epilepsy treatment.

Keywords: antiepileptic drugs; children; cost of pharmacotherapy; epilepsy; pediatric patients with epilepsy; pharmacoeconomics; quality of life.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

References

    1. George J., Kulkarni C., Sarma G.R.K. Antiepileptic Drugs and Quality of Life in Patients with Epilepsy: A Tertiary Care Hospital-Based Study. Value Health Reg. Issues. 2015;6:1–6. doi: 10.1016/j.vhri.2014.07.009. - DOI - PubMed
    1. Sarangi S.C., Kaur N., Tripathi M. Need for pharmacoeconomic consideration of antiepileptic drugs monotherapy treatment in persons with epilepsy. Saudi Pharm. J. 2020;28:1228–1237. doi: 10.1016/j.jsps.2020.08.013. - DOI - PMC - PubMed
    1. Privitera M. Current challenges in the management of epilepsy. Am. J. Manag. Care. 2011;17((Suppl. 7)):S195–S203. - PubMed
    1. Lee S.K. Old versus New: Why Do We Need New Antiepileptic Drugs? J. Epilepsy Res. 2014;4:39–44. doi: 10.14581/jer.14010. - DOI - PMC - PubMed
    1. Rosati A., De Masi S., Guerrini R. Antiepileptic Drug Treatment in Children with Epilepsy. CNS Drugs. 2015;29:847–863. doi: 10.1007/s40263-015-0281-8. - DOI - PMC - PubMed

Substances